All In Biotech

Free tool

FAERS Monitor: Lyrica

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021723 or its brand name (Lyrica, Pregabalin). Reports on generic versions are filed under their own applications.

Reports

273,908

Serious

183,607

67% of reports

Hospitalization

78,429

Death reported

22,698

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective27,200
  • pain26,508
  • fatigue15,853
  • dizziness15,031
  • nausea14,720
  • off label use14,004
  • headache13,242
  • malaise12,999
  • somnolence11,958
  • weight increased11,711
  • pain in extremity11,488
  • fall11,138
  • dyspnoea10,618
  • diarrhoea10,340
  • insomnia9,827

Reports by year received

View as table
YearReports
20045
2005351
20064,998
20072,871
20083,560
20093,001
201013,566
20116,904
201213,074
201314,156
201416,247
201518,634
201619,912
201718,062
201820,542
201922,875
202018,930
202114,842
202213,309
202311,934
202413,545
202513,013
20269,577

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,780,251 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
somnolenceSignal11,9584.84.733,998
weight increasedSignal11,7114.24.127,157
painSignal26,5083.43.444,690
pain in extremitySignal11,4883.13.015,673
insomniaSignal9,8272.92.811,959
fallSignal11,1382.62.610,993
dizzinessSignal15,0312.42.311,639
malaiseSignal12,9992.32.39,620
headache13,2421.61.63,296
drug ineffective27,2001.61.66,344
fatigue15,8531.61.63,388
dyspnoea10,6181.41.41,488
nausea14,7201.41.41,989
diarrhoea10,3401.21.2465
off label use14,0041.21.2627

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.